L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo
- 10 September 2015
- journal article
- Published by American Society of Hematology in Blood
- Vol. 126 (11) , 1336-1345
Abstract
B-cell Chronic Lymphocytic Leukemia (CLL) is the most common leukemia in adults. Lymph nodes are sites of malignant proliferation and lymph node enlargement is associated with poor prognosis in the clinics. The lymph node microenvironment is believed to favor disease progression by promoting CLL cell growth and drug resistance. A better understanding of the mechanisms regulating trafficking of CLL cells to lymph nodes is thus urgently needed. Here, we studied the first step of CLL cells migration to lymph nodes, their interaction with high endothelial venules (HEVs), specialized blood vessels for lymphocyte extravasation in lymphoid organs. We observed that the density of HEV blood vessels was increased in CLL lymph nodes and that CD20+ CLL cells accumulated within HEV pockets, suggesting intense trafficking. We used intravital imaging to visualize the behavior of human CLL cells within the mouse lymph node microcirculation, and discovered that CLL cells bind to HEVs in vivo via a multistep adhesion cascade, which involves rolling, sticking and crawling of the leukemic cells on the endothelium. Functional analyses revealed that the lymphocyte homing receptor L-selectin (CD62L) is the key factor controlling the binding of CLL cells to HEV walls in vivo. Interestingly, L-selectin expression was decreased on CLL cells from patients treated with idelalisib, a phosphoinositide-3-kinase δ inhibitor recently approved for CLL therapy. Interference with L-selectin-mediated trafficking in HEVs could represent a novel strategy to block dissemination of CLL cells to lymph nodes and increase the efficacy of conventional therapy.Keywords
This publication has 36 references indexed in Scilit:
- How the microenvironment wires the natural history of chronic lymphocytic leukemiaSeminars in Cancer Biology, 2014
- Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signalingBlood, 2013
- Molecular pathogenesis of chronic lymphocytic leukemiaJournal of Clinical Investigation, 2012
- Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approachesLeukemia & Lymphoma, 2012
- Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targetingSeminars in Cancer Biology, 2010
- The microenvironment in mature B-cell malignancies: a target for new treatment strategiesBlood, 2009
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005
- Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomasBlood, 2004
- Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular disseminationJournal of Leukocyte Biology, 2004
- The chemokine receptor CCR7 and α4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodesBlood, 2002